COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Narrative Intervention for Long COVID-19 (NICO)

Not Applicable

Completed

Conditions: Long Covid19
Long COVID

Interventions: Behavioral: Narrative Intervention for Long COVID-19 (NICO)

First Posted Date: 2023-10-19

Last Posted Date: 2024-12-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 12

Registration Number: NCT06091293

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

SHARE Approach Evaluation

Completed

Conditions: Shared Decision Making

Interventions: Behavioral: SHARE Approach

First Posted Date: 2023-10-02

Last Posted Date: 2024-08-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 176

Registration Number: NCT06062940

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Group Interval Fitness Program for Adolescents With Cognitive Impairments in the School Setting.

Not Applicable

Not yet recruiting

Conditions: Cognitive Impairment

Interventions: Other: Group exercise program

First Posted Date: 2023-09-29

Last Posted Date: 2023-11-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 60

Registration Number: NCT06061900

Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

Not Applicable

Completed

Conditions: Interpersonal Psychotherapy
Polycystic Ovary Syndrome

Interventions: Behavioral: Interpersonal Psychotherapy

First Posted Date: 2023-09-28

Last Posted Date: 2023-09-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 30

Registration Number: NCT06056453

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Fully Closed Loop At Home (FCL@Home)

Not Applicable

Active, not recruiting

Conditions: Type 1 Diabetes

Interventions: Device: AIDANET system

First Posted Date: 2023-09-18

Last Posted Date: 2024-12-18

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 36

Registration Number: NCT06041971

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Barbara Davis Center, Aurora, Colorado, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Advair HFA in Healthy and HAPE Predisposed Subjects

Phase 1

Recruiting

Conditions: Altitude Edema

Interventions: Drug: Advair HFA
Drug: Placebo

First Posted Date: 2023-09-15

Last Posted Date: 2023-12-14

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 60

Registration Number: NCT06040268

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Parent Management Training to Treat Irritability

Not Applicable

Recruiting

Conditions: Irritable Mood
Anger
Temper Tantrum

Interventions: Behavioral: Parent Management Training

First Posted Date: 2023-08-31

Last Posted Date: 2024-12-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 36

Registration Number: NCT06020261

Locations: 🇺🇸
Childrens Hospital Colorado, Aurora, Colorado, United States

Reducing Asthma Attacks in Disadvantaged School Children With Asthma

Not Applicable

Recruiting

Conditions: Asthma in Children

Interventions: Behavioral: BACK-S
Behavioral: BACK-E

First Posted Date: 2023-08-22

Last Posted Date: 2024-06-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 500

Registration Number: NCT06003569

Locations: 🇺🇸
Ault-Highland RE-9 school district, Ault, Colorado, United States
🇺🇸
Colorado Springs 11, Colorado Springs, Colorado, United States
🇺🇸
Ellicott 22 school district, Ellicott, Colorado, United States

and more 10 locations

Effects of Continuous Positive Airway Pressure on Peripheral Oxygen Saturation, Work of Breathing, and Exercise Tolerance at Altitude

Not Applicable

Conditions: Hypoxemia
Altitude Hypoxia

Interventions: Device: Ambient air
Device: Continuous positive airway pressure

First Posted Date: 2023-08-02

Last Posted Date: 2023-08-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 25

Registration Number: NCT05971290

Locations: 🇺🇸
University of Colorado Denver, Denver, Colorado, United States

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus

Phase 2

Recruiting

Conditions: Kidney Cancer
Renal Cancer
Inferior Vena Cava Thrombosis
Renal Cell Carcinoma

Interventions: Drug: Axitinib
Drug: Pembrolizumab

First Posted Date: 2023-08-01

Last Posted Date: 2024-10-23

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 17

Registration Number: NCT05969496

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy